Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
---|---|---|---|---|---|
10208-2 | JNK-IN-5A | TCS JNK 5a; KIN001-188 | LSM-1209 | 766949 | |
10223-2 | AG1478 | Tyrphostin | LSM-1224 | 2051 | |
10230-2 | Lestaurtinib | CEP-701 | LSM-1231 | 126565 | |
10266-1 | NSC 663284 | LSM-2042 | 379077 | ||
10249-1 | Epirubicin | Ellence | LSM-2078 | 41867 | |
10246-1 | CPT-11 | Irinotecan | LSM-2167 | 60838 | |
10228-2 | IKK16 | LSM-2309 | 9549298 | ||
10273-1 | Purvalanol A | LSM-3118 | 456214 | ||
10271-2 | PD 98059 | LSM-3394 | 4713 | ||
10280-1 | Triciribine | LSM-3810 | 65399 | ||
10282-1 | Vorinostat | suberoylanilide hydroxamic acid (SAHA); Zolinza | LSM-3828 | 5311 | |
10248-1 | Doxorubicin | Adriamycin | LSM-4062 | 31703 | |
10232-2 | Dactolisib | BEZ235; NVP-BEZ235 | LSM-4255 | 11977753 | |
10235-2 | Everolimus | RAD001 | LSM-4258 | 53398658 | |
10238-1 | 5-FU | Fluorouracil | LSM-4261 | 3385 | |
10239-1 | AG1024 | Tyrphostin AG 1024 | LSM-4262 | 2044 | |
10240-1 | AS-252424 | LSM-4263 | 56965900 | ||
10243-1 | CGC-11047 | PG11047 | LSM-4266 | 476863 | |
10245-1 | Cisplatin | CDDP; cis-Diaminodichloroplatinum; Cisplatinum; Lederplatin; Briplatin; Cismaplat | LSM-4268 | ||
10251-1 | Fascaplysin | LSM-4272 | 73293 | ||
10253-1 | Glycyl-H-1152 | LSM-4274 | |||
10255-1 | GSK1838705A | LSM-4276 | 25182616 | ||
10257-1 | GSK923295 | LSM-4278 | 68651179 | ||
10108-2 | Geldanamycin | LSM-42789 | 644250 | ||
10258-1 | Ibandronate | Boniva | LSM-4279 | 44828485 |